Jefferson to eliminate 500 positions and trim top executives’ pay as losses mount from COVID-19
Jefferson, Philadelphia’s second largest employer, is leaving 500 to 600 positions unfilled after a year of big losses.
Related Articles
Microplastics are detected in human gallstones and have the ability to form large cholesterol-microplastic heteroaggregates
Ubiquitous pollution due to microplastics through the food chain is a major cause of various deleterious effects on the human health. The aim of this…
Underestimated burden of per- and polyfluoroalkyl substances in global surface waters and groundwaters
Nature Geoscience – A global data analysis suggests that a large fraction of surface waters and groundwaters globally have concentrations of per- and polyfluoroalkyl substances…
Checkpoint Inhibitors: A New Hope for Cancer Treatment
Checkpoint inhibitors revolutionized the way we treat aggressive cancers. This article explores this treatment’s roots and hints at future applications.
Thioredoxin is a metabolic rheostat controlling regulatory B cells
Nature Immunology – Here the authors show a mechanism by which mitochondrial electron transport and ROS contribute to the differentiation and function of regulatory B…
5 Ways Artificial Intelligence Is Changing Healthcare
While the artificial intelligence revolution has just begun, it is transforming healthcare, speeding drug discovery, improving both diagnosis and patient communication.
Environmentally dependent and independent control of 3D cell shape
Using high-throughput light-sheet microscopy, Dent et al. study 3D cancer cell morphogenesis. Environmental cues modulate the opposing roles of non-muscle myosin II (myosin) and microtubules, with…
SARS-CoV-2 spike S2 subunit inhibits p53 activation of p21(WAF1), TRAIL Death Receptor DR5 and MDM2 proteins in cancer cells
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and COVID-19 infection has led to worsened outcomes for patients with cancer. SARS-CoV-2 spike protein mediates host cell…
Clinical Benefit and Regulatory Outcomes of Cancer Drugs Receiving Accelerated Approval
This study aims to determine whether cancer drugs granted accelerated approval from the US Food and Drug Administration ultimately demonstrate clinical benefit and to evaluate…
Shocking Study Reveals Many Fast-Tracked Cancer Drugs Offer No Clinical Benefit
This is not what we wanted to see.
Drug shortages reach record high in US | CNN
There are more active drug shortages in the United States than ever, according to data from the American Society of Health-System Pharmacists and the University of…